From April 2022, Valcyte 50 mg/mL powder for oral solution will be provided with a new dispenser.

The purpose of this notice is to inform prescribers of the new millilitre (mL) scale on the dispenser of Valcyte 50 mg/mL powder for oral solution in order to avoid potential dosage errors.

It should be noted that the dose of Valcyte will continue to be calculated in mg; therefore, prescribers will need to convert to mL to allow the correct dose to be administered.

For ease of consultation, a picture of the currently authorised dispenser and the new version that will be placed on the market from April 2022 is provided below.